Preferred
(EDT)
Other
Bioengineering Cells and Viruses in Disease
Engineering E. coli for the Targeted Injections of Proteins into Tumor Cells
5:00 PM - 5:25 PM EDT
Monday, May 3, 2021Speaker
Luis Ángel Fernández, PhD
National Center of Biotechnology - CSIC
Bioengineering Cells and Viruses in Disease
Synthetic Immunotherapy with Engineered Bacteria
5:25 PM - 5:50 PM EDT
Monday, May 3, 2021Speaker
Jose Lora, PhD
enGene, Inc
Bioengineering Cells and Viruses in Disease
New Strategies for Improving the Therapeutic Potential of Oncolytic Viruses in Cancer and Other Diseases
5:50 PM - 6:15 PM EDT
Monday, May 3, 2021Speaker
Howard Kaufman, MD
Massachusetts General Hospital
Bioengineering Cells and Viruses in Disease
Engineering Bacteria and Yeast for the Control of Inflammation
6:15 PM - 6:40 PM EDT
Monday, May 3, 2021Speaker
Francisco Quintana, PhD
Professor of Neurology, Harvard Medical School and the Broad Institute of MIT and Harvard
Bioengineering Cells and Viruses in Disease
Coffee Break
6:40 PM - 6:55 PM EDT
Monday, May 3, 2021Bioengineering Cells and Viruses in Disease
Metabolic Modulation of the Tumor Microenvironment with Synthetic Biology
6:55 PM - 7:20 PM EDT
Monday, May 3, 2021Speaker
Roger Geiger, PhD
Institute for Research in Biomedicine
Bioengineering Cells and Viruses in Disease
Leveraging Bacterial Secretion Systems to Develop Therapeutic Designer Probiotics
7:20 PM - 7:45 PM EDT
Monday, May 3, 2021Speaker
Cammie Lesser, MD, PhD
Massachusetts General Hospital
Bioengineering Cells and Viruses in Disease
Short Talk: Development of Designer Probiotics for the Treatment of Inflammatory Bowel Disease
7:45 PM - 8:00 PM EDT
Monday, May 3, 2021Speaker
Jason Lynch, PhD
Massachusetts General Hospital
Bioengineering Cells and Viruses in Disease
